Cartesian Therapeutics, Inc.

Biotechnology • Healthcare • Frederick, MD, United States • RNAC (NGM)

Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company's lead product candidate is Descartes-08, an autologous mRNA CAR-T directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease designation for the treatment of juvenile dermatomyositis. It is also developing Descartes-15, an autologous anti-BCMA mRNA CAR-T to treat autoimmune diseases, such as relapsed/refractory multiple myeloma. The company is headquartered in Frederick, Maryland.

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors - Yahoo Finance

Yahoo Finance • Dec 18

HC Wainwright & Co. Maintains Cartesian Therapeutics (RNAC) Buy Recommendation - Nasdaq

Nasdaq • Nov 19

Cartesian Therapeutics Appoints Dr. Adrian Bot to Board of Directors - Quiver Quantitative

Quiver Quantitative • Dec 18

Cartesian stock rebounds after insider buy (RNAC:NASDAQ) - Seeking Alpha

Seeking Alpha • Dec 9

Cartesian (NASDAQ: RNAC) posts 100% LLDAS in SLE; expands Descartes-08 into myositis - Stock Titan

Stock Titan • Nov 13

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Cartesian Therapeutics, Inc. had layoffs?

No layoff events have been recorded for Cartesian Therapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Cartesian Therapeutics, Inc. have?

Cartesian Therapeutics, Inc. has approximately 66 employees.

What industry is Cartesian Therapeutics, Inc. in?

Cartesian Therapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Cartesian Therapeutics, Inc. a publicly traded company?

Yes, Cartesian Therapeutics, Inc. is publicly traded under the ticker symbol RNAC on the NGM. The company has a market capitalization of approximately $0.17 billion.

Where is Cartesian Therapeutics, Inc. headquartered?

Cartesian Therapeutics, Inc. is headquartered in Frederick, MD, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.